RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Lawrence Albers to Isoxazoles

Back to Details
This is a "connection" page, showing publications Lawrence Albers has written about Isoxazoles.
Lawrence Albers
Connection Strength
0.312
Isoxazoles
  1. Albers LJ, Musenga A, Raggi MA. Iloperidone: a new benzisoxazole atypical antipsychotic drug. Is it novel enough to impact the crowded atypical antipsychotic market? Expert Opin Investig Drugs. 2008 Jan; 17(1):61-75.
    View in: PubMed
    Score: 0.312
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support